{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"Answers from the Lab","title":"New Panels Help Find Cause of Rapidly Progressive Dementia: Gregory (Gregg) Day, M.D.","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/34cc1863\"></iframe>","width":"100%","height":180,"duration":1457,"description":"Rapidly progressive dementia covers many conditions, including Creutzfeldt-Jacob disease (CJD). Gregory (Gregg) Day, M.D., explains how Mayo Clinic Laboratories' new evaluations help identify the cause of rapidly progressive dementia, to guide prognosis and treatment decisions.\nShow notes\nSpeaker 3: (00:32)\nCan you provide a little background about your role here at Mayo Clinic and experience with this disease state?\n \nSpeaker 3: (01:21)\n Can you give us an understanding of rapidly progressive dementia? How is it different and what should physicians be looking for?\n \nSpeaker 3: (03:13)\n You mentioned \"syndromic\" and that there are several diseases underneath that, one of them being Creutzfeldt-Jacob. Can you explain the others in a bit more detail? What makes them each unique under the heading of rapidly progressive dementias?\n \nSpeaker 3: (05:29)\n Does that encompass it: prion diseases, then the neurodegenerative bucket, then autoimmune?\n \nSpeaker 3: (06:03)\n Can you speak to the components of the new Creutzfeldt-Jacob disease-specific evaluation and the rapidly progressive dementia evaluation, and the assays that they're performed on?\n \nSpeaker 3: (09:30)\n Anything you want to add to that summary of the assays' components?\n \nSpeaker 3: (11:09)\n Can you explain the role — or lack thereof — of the 14-3-3 protein biomarker, according to our research?\n \nSpeaker 3: (13:44)\n Which patients should get this testing, and who should not?\n \nSpeaker 3: (17:22)\n What does it mean if the results come back positive and if the results come back negative?\n \nSpeaker 3: (21:57)\n What are you most excited about with these tests?","thumbnail_url":"https://img.transistorcdn.com/jhRCftFebxnTMwoIbA_WoqrSKwFRD_Y2kbh0JDjhx14/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjNj/ZDc0NTE0MWNlOWRl/YzRiN2Q3NDg2Mjg5/YWE4MS5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}